REFERENCES
- Modell B, Darlison M. Global epidemiology of haemoglobin disorders and derived service indicators. Bull World Health Organ 2008;86(6):480–487.
- Patrinos GP, Giardine B, Riemer C, Improvements in the HbVar database of human hemoglobin variants and thalassemia mutations for population and sequence variation studies. Nucleic Acids Res 2004;32( Database issue):D537–541.
- Samavat A, Modell B. Iranian national thalassaemia screening programme. BMJ 2004;329(7475):1134–1137.
- Najmabadi H, Karimi-Nejad R, Sahebjam S, The β-thalassemia mutation spectrum in the Iranian population. Hemoglobin 2001;25(3):285–296.
- Hosseinpour Feizi MA, Hosseinpour Feizi AA, Pouladi N, Haghi M, Azarfam P. Molecular spectrum of β-thalassemia mutations in Northwestern Iran. Hemoglobin 2008;32(3):255–261.
- Haghi M, Khorshidi S, Hosseinpour Feizi MA, Pouladi N, Hosseinpour Feizi AA. β-Thalassemia mutations in the Iranian Kurdish population of Kurdistan and West Azerbaijan provinces. Hemoglobin 2009;33(2):109–114.
- Derakhshandeh-Peykar P, Akhavan-Niaki H, Tamaddoni A, Distribution of β-thalassemia mutations in the northern provinces of Iran. Hemoglobin 2007;31(3):351–356.
- Eshghi P, Zadeh-Vakili A, Rashidi A, Miri-Moghadam E. An unusually frequent β-thalassemia mutation in an Iranian province. Hemoglobin 2008;32(4):387–392.
- Kiani AA, Mortazavi Y, Zeinali S, Shirkhani Y. The molecular analysis of β-thalassemia mutations in Lorestan Province, Iran. Hemoglobin 2007;31(3):343–349.
- Yavarian M, Harteveld CL, Batelaan D, Bernini LF, Giordano PC. Molecular spectrum of β-thalassemia in the Iranian province of Hormozgan. Hemoglobin 2001;25(1):35–43.
- Rahimi Z, Muniz A, Akramipour R, Haplotype analysis of β thalassemia patients in Western Iran. Blood Cells Mol Dis 2009;42(2):140–143.
- Old JM, Khan SN, Verma I, A multi-center study to further define the molecular basis of β-thalassemia in Thailand, Pakistan, Sri Lanka, Mauritius, Syria, and India, and to develop a simple molecular diagnostic strategy by amplification refractory mutation system polymerase chain reaction. Hemoglobin 2001;25(4):397–407.
- Stuve LL, Myers RM. A directly repeated sequence in the β-globin promoter regulates transcription in murine erythroleukemia cells. Mol Cell Biol 1990;10(3):972–981.
- Badens C, Jassim N, Martini N, Mattei JF, Elion J, Lena-Russo D. Characterization of a new polymorphism, IVS-I-108 (T→C), and a new β-thalassemia mutation, −27 (A→T), discovered in the course of a prenatal diagnosis. Hemoglobin 1999;23(4):339–344.
- Muñiz A, Martinez G, Lavinha J, Pacheco P. β-Thalassaemia in Cubans: novel allele increases the genetic diversity at the HBB locus in the Caribbean. Am J Hematol 2000;64(1):7–14.
- Alibert C, Tazi J, Temsamani J, Jeanteur P, Brunel C, Cathala G. Interplay between U2 snRNP and 3′ splice factor(s) for branch point selection on human β-globin pre-mRNA. Nucleic Acids Res 1990;18(2):235–245.